Patients with axial length ≤22.5mm will be recruited. The subjects will undergo bilateral uneventful phacoemulsification and implantation of PanOptix. Visual quality and patients satisfactory will be assessed three months after the surgery.
To evaluate visual outcomes and patient satisfactory after PanOptix implantation in hyperopic cataract patients